Federal Court determines Minister’s decisions granting NOCS based on administrative ANDSs cross-referencing licensed generics without requiring NOAs are wrong – …
The year in review: 2014 highlights in Canadian pharmaceutical IP and regulatory news – Lexology.
Consolidated CETA text released – Patent term restoration and innovator right of appeal in PMNOC proceedings part of EU trade …
Federal Court of Appeal updates the law of section 8 damages – Lexology.
Pay-for-delay to Stay FTC’s Top Priority | McDermott Will & Emery – JDSupra.
Protecting Data Exclusivity, Protecting the Future of Medicine – IPWatchdog.com | Patents & Patent Law.
Ontario’s worst fear about CETA isn’t realized – The Globe and Mail.
Article > EU trade deal give pharma two years’ patent gain in Canada.
Why the Bad Rap on Generic Drugs? – NYTimes.com.
GEN | News Highlights:Allergan Licenses Rights to Medytox Candidates, in Up-to-$362M Deal.